The new carrier-free prodrug nanoparticles are prepared by self-assembly of cancer-specific prodrugs, constructed with tumor-overexpressed cathepsin B-specific cleavable peptide FRRG and DOX (FRRG-DOX). Here, CTSB is linked to neoplasm.